`
`
`
`
`CENTER FOR DRUG EVALUATION AND
`RESEARCH
`
`
`
`APPLICATION NUMBER:
`
`211192Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`July 17, 2018
`
`Administrative file for NDA 211192
`
`NDA 211192, Tibsovo® (ivosidenib) tablets
`
`
`MEMORANDUM
`
`
`
`
`DATE:
`
`TO:
`
`FROM:
`
`
`SUBJECT: Officer/Employee List for NDA 211192
`
`APPLICATION/DRUG:
`
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Carioti, Theresa
`Conklin, Rachel
`Dorantes, Angelica
`Dorff, Sarah
`Earp, Justin
`Farrell, Ann
`Fuller, Barbara
`Gudi, Ramadevi
`Haider, Rabiya
`Hsu, Vicky
`Leaman, Diane
`Leighton, John
`Luo, Lola
`McLamore-Hines, Sherita
`Mehta, Hina
`Mitra, Amit
`Norsworthy, Kelly
`Olickal, Till
`Philip, Reena
`Przepiorka, Donna
`Rahimi, Leeza
`Redwood, Susan
`Schetter, Aaron
`Shen, Yuan-Li
`Sheth, Christopher
`
`
`Laura Wall, Regulatory Health Project Manager
`Division of Hematology Products, Office of Hematology and Oncology Products
`
`Reference ID: 4292711
`
`
`
`
`Sridhara, Rajeshwari
`Tiwari, Rohit
`Vora, Neil
`Wall, Laura
`
`
`
`
`Reference ID: 4292711
`
`
`
`Signature Page 1 of 1
`--------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically. Following this are manifestations of any and all
`electronic signatures for this electronic record.
`--------------------------------------------------------------------------------------------
`/s/
`------------------------------------------------------------
`
`LAURA C WALL
`07/17/2018
`
`Reference ID: 4292711
`
`(
`
`
`
`